Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivia Campagne

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Journal of Clinical Pharmacology|October 30, 2018
Population Pharmacokinetics of Tacrolimus in Transplant Recipients: What Did We Learn About Sources of Interindividual Variabilities?Olivia Campagne, Donald E Mager, Kathleen M Tornatore
Biomedical Chromatography : BMC|September 10, 2019
An LC/ESI-MS/MS method to quantify the PI3K inhibitor GDC-0084 in human plasma and cerebrospinal fluid: Validation and clinical applicationBo Zhong, Olivia Campagne, Christopher L Tinkle, et al.
Clinical Pharmacokinetics|December 23, 2020
Clinical Pharmacokinetics and Pharmacodynamics of SelumetinibOlivia Campagne, Kee Kiat Yeo, Jason Fangusaro, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 3, 2020
LC-MS/MS method for quantitation of the CK2 inhibitor silmitasertib (CX-4945) in human plasma, CSF, and brain tissue, and application to a clinical pharmacokinetic study in children with brain tumorsBo Zhong, Olivia Campagne, Ralph Salloum, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2022
Population pharmacokinetics of crenolanib in children and young adults with brain tumorsCora Bisbee, Olivia Campagne, Amar Gajjar, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 26, 2021
Development and validation of an LC-MS/MS method to quantify the bromodomain and extra-terminal (BET) inhibitor JQ1 in mouse plasma and brain microdialysate: Application to cerebral microdialysis studySreenath Nair, Abigail Davis, Olivia Campagne, et al.
Clinical and Translational Science|June 1, 2021
Pharmacokinetically guided dosing of oral sorafenib in pediatric hepatocellular carcinoma: A simulation studyJohn C Panetta, Olivia Campagne, Jessica Gartrell, et al.
Molecules (Basel, Switzerland)|September 9, 2022
Development and Validation of a Sensitive and Specific LC-MS/MS Method for IWR-1-Endo, a Wnt Signaling Inhibitor: Application to a Cerebral Microdialysis StudySreenath Nair, Abigail Davis, Olivia Campagne, et al.
Drug Metabolism and Pharmacokinetics|January 20, 2023
CNS penetration of methotrexate and its metabolite 7-hydroxymethotrexate in mice bearing orthotopic Group 3 medulloblastoma tumors and model-based simulations for childrenRachel S Perkins, Abigail Davis, Olivia Campagne, et al.
Journal of Clinical Pharmacology|May 19, 2018
Tacrolimus Population Pharmacokinetics and Multiple CYP3A5 Genotypes in Black and White Renal Transplant RecipientsOlivia Campagne, Donald E Mager, Daniel Brazeau, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Journal of Clinical Pharmacology|October 30, 2018
Population Pharmacokinetics of Tacrolimus in Transplant Recipients: What Did We Learn About Sources of Interindividual Variabilities?Olivia Campagne, Donald E Mager, Kathleen M Tornatore
Biomedical Chromatography : BMC|September 10, 2019
An LC/ESI-MS/MS method to quantify the PI3K inhibitor GDC-0084 in human plasma and cerebrospinal fluid: Validation and clinical applicationBo Zhong, Olivia Campagne, Christopher L Tinkle, et al.
Clinical Pharmacokinetics|December 23, 2020
Clinical Pharmacokinetics and Pharmacodynamics of SelumetinibOlivia Campagne, Kee Kiat Yeo, Jason Fangusaro, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 3, 2020
LC-MS/MS method for quantitation of the CK2 inhibitor silmitasertib (CX-4945) in human plasma, CSF, and brain tissue, and application to a clinical pharmacokinetic study in children with brain tumorsBo Zhong, Olivia Campagne, Ralph Salloum, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2022
Population pharmacokinetics of crenolanib in children and young adults with brain tumorsCora Bisbee, Olivia Campagne, Amar Gajjar, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 26, 2021
Development and validation of an LC-MS/MS method to quantify the bromodomain and extra-terminal (BET) inhibitor JQ1 in mouse plasma and brain microdialysate: Application to cerebral microdialysis studySreenath Nair, Abigail Davis, Olivia Campagne, et al.
Clinical and Translational Science|June 1, 2021
Pharmacokinetically guided dosing of oral sorafenib in pediatric hepatocellular carcinoma: A simulation studyJohn C Panetta, Olivia Campagne, Jessica Gartrell, et al.
Molecules (Basel, Switzerland)|September 9, 2022
Development and Validation of a Sensitive and Specific LC-MS/MS Method for IWR-1-Endo, a Wnt Signaling Inhibitor: Application to a Cerebral Microdialysis StudySreenath Nair, Abigail Davis, Olivia Campagne, et al.
Drug Metabolism and Pharmacokinetics|January 20, 2023
CNS penetration of methotrexate and its metabolite 7-hydroxymethotrexate in mice bearing orthotopic Group 3 medulloblastoma tumors and model-based simulations for childrenRachel S Perkins, Abigail Davis, Olivia Campagne, et al.
Journal of Clinical Pharmacology|May 19, 2018
Tacrolimus Population Pharmacokinetics and Multiple CYP3A5 Genotypes in Black and White Renal Transplant RecipientsOlivia Campagne, Donald E Mager, Daniel Brazeau, et al.
Pageof 4